BRD-7389

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBRD-7389
Drug Alias NameBRD-7389
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRibosomal protein S6 kinase inhibitors
TargetsRibosomal protein S6 kinase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBroad Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBroad Institute
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A